CAH
53
6
BSX
70
2
VRSK
77
4
CMG
67
3
O
22
2
AMG
52
2
CAT
62
7
ACN
49
2
URBN
42
4
AON
52
2
HP
45
4
FOXA
59
4
DE
56
10
CB
51
3
GPC
37
2
GT
56
2
FE
52
3
FTI
76
3
ORCL
67
2
VTR
54
5
CAH
53
6
BSX
70
2
VRSK
77
4
CMG
67
3
O
22
2
AMG
52
2
CAT
62
7
ACN
49
2
URBN
42
4
AON
52
2
HP
45
4
FOXA
59
4
DE
56
10
CB
51
3
GPC
37
2
GT
56
2
FE
52
3
FTI
76
3
ORCL
67
2
VTR
54
5
Financhill
Back

Malibu Boats 10K Form

Sell
36

MBUU
Malibu Boats

Last Price:
42.04
Seasonality Move:
12.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MBUU News And Ratings

See the #1 stock for the next 7 days that we like better than MBUU

MBUU Financial Statistics

Sales & Book Value

Annual Sales: $829.04M
Cash Flow: $-17.03M
Price / Cash Flow: 16.92
Annual Sales: $26.04
Price / Book: 1.6

Profitability

EPS (TTM): -3.98000
Net Income (TTM): $-81.22M
Gross Margin: $147.1M
Return on Equity: -14.12%
Return on Assets: -9.91%

Malibu Boats Earnings Forecast

Key Malibu Boats Financial Ratios

  • The Gross Profit Margin over the past 14 years for MBUU is 17.74%.
  • The Selling, General & Administrative Expenses for MBUU have been equal to 11.95% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -3.29% of Operating Income.
  • The Net Earning history of MBUU is -6.74% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

Malibu Boats Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Leisure Products
Sector: Consumer Discretionary
Current Symbol: MBUU
CUSIP: 56117J
Website: malibuboats.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 1.55
Quick Ratio: 0.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 10.94

MBUU Technical Analysis vs Fundamental Analysis

Sell
36
Malibu Boats (MBUU) is a Sell

Is Malibu Boats a Buy or a Sell?

  • Malibu Boats stock is rated a Sell
    The current Malibu Boats [MBUU] share price is $42.06. The Score for MBUU is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.